Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DI37UY
|
|||
| Drug Name |
Viralym-M
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Virus infection [ICD-11: 1A24-1D9Z] | Phase 2 | [1] | |
| Company |
ViraCyte
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04693637) Study of Viralym-M (ALVR105) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.